What is Sitagliptin?

Category: Prescription Drugs

Most popular types: Januvia

false

Sitagliptin is an antidiabetic agent use in the treatment of noninsulin dependent diabetes as an adjunct to diet and exercise as a single agent or in combination therapy with other antidiabetic agents.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Diabetes type 2 174 61
Weight gain 2 1
Bowel problems 1 0
Churg-Strauss syndrome 1 0
Excess saliva 1 1

Show all 15 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 8
Moderate 3
Mild 7
None 55

Commonly reported side effects and conditions associated with Sitagliptin

Side effect Patients Percentage
Abdominal pain 1
Breathlessness 1
Chronic diarrhea 1
Decreased appetite 1
Elevated blood sugar (hyperglycemia) 1
Frequent daytime urination 1

Show all 16 reported side effects

Dosages

Based on patients currently taking Sitagliptin

Dosage Patients Percentage
100 mg daily 12
25 mg daily 4
50 mg daily 4

Why patients stopped taking Sitagliptin

Multiple reasons could be selected

Reason Patients Percentage
Doctor's advice 22
Did not seem to work 13
Side effects too severe 11
Other 7
Expense 6
Change in health plan coverage 5
Course of treatment ended 1
Personal research 1
See all 53 patients who've stopped taking Sitagliptin

Duration

Currently taking Sitagliptin

Duration Patients Percentage
6 months - 1 year 1
1 - 2 years 3
2 - 5 years 10
5 - 10 years 4
10 years or more 2

Stopped taking Sitagliptin

Duration Patients Percentage
Less than 1 month 10
1 - 6 months 8
6 months - 1 year 8
1 - 2 years 11
2 - 5 years 12
5 - 10 years 4
Adherence
Adherence Evaluations Percentage
Always 62
Usually 5
Sometimes 1
Never taken as prescribed 5
Burden
Burden Evaluations Percentage
Very hard to take 5
Somewhat hard to take 2
A little hard to take 4
Not at all hard to take 62
Cost per month
Cost per month Evaluations Percentage
$200+ 3
$100-199 1
$50-99 6
$25-49 9
< $25 29
Not specified 25

What people switch to and from

Patients started taking Sitagliptin after stopping:

Treatment Patients Percentage
Metformin (Metformin ER) 15
Glipizide (Glipizide ER) 4
Insulin Glargine (Lantus) 2
Alogliptin 1
Canagliflozin (Invokana) 1

Show all 12 treatments patients report switching from

Patients stopped taking Sitagliptin and switched to:

Treatment Patients Percentage
Sitagliptin-metformin (Janumet) 6
Metformin (Metformin ER) 5
Insulin Glargine (Lantus) 3
Linagliptin (Tradjenta) 3
Dulaglutide (Trulicity) 2

Show all 20 treatments patients report switching to

Last updated:

2 patient evaluations for Sitagliptin

Jun 25, 2012 (Started May 26, 2012)

  • Effectiveness
    Major (for diabetes type 2)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 50 mg Daily
Advice & Tips: VA Medical does not cover
Cost: < $25 monthly

  • 0 helpful marks

Jul 1, 2011 (Started Jul 01, 2010)

  • Effectiveness
    None (for diabetes type 2)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 50 mg Daily
Advice & Tips: I was afraid of getting cancer.
Cost: $25-49 monthly

  • 0 helpful marks
Last updated:
Showing 2 of 2 patient evaluations for Sitagliptin